baber/WOPTO huggingface dataset:
Patent NZ-549072-A (NZ)
Title: Combustion promoting device for internal combustion engine
Inventor: JUN BYOUNG PYO
Filed: 2006-08-10
Abstract: Disclosed is a combustion promoting device for an internal combustion engine which derives high combustion efficiency and high power from the internal combustion engine. The combustion promoting device is provided with a combustion promotion inductor formed of a super alloy having excellent heat resistance and thermal conductivity. The combustion promotion inductor is adapted to absorb high-temperature heat generated when an explosion stroke takes place. This absorption of the high-temperature heat allows the combustion promotion inductor to be maintained in a pre-heated state at all times, thereby serving as a kindler (a promoter generating a spark). As a result, the combustion promotion inductor rapidly increases the temperature of an air-fuel mixture introduced again after an exhaust stroke to reinforce the explosive force concomitant with the thermal expansion, thereby allowing the internal combustion engine to obtain high power.
Patent NZ-550027-A (NZ)
Title: Systems and methods for providing a stem cell bank
Inventor: KAMINSKI JOSEPH K
IPC: G16H10/60
Filed: 2005-03-22
Abstract: A computer system for maintaining a computer based stem cell registry comprises a central processing unit and a memory, coupled to the central processing unit. The memory stores a stem cell database comprising information about stem cell units; and a stem cell tracking module. The stem cell tracking module comprises a data entry routine that comprises: instructions for enrolling a donor in the stem cell database and instructions for receiving characterization information of one or more placental stem cell units that originate from the donor. A placental stem cell unit in the one or more placental stem cell units comprises a plurality of placental stem cell transplant units and each placental stem cell transplant unit in the plurality of placental stem cell transplant units shares the same characterization information of the the placental stem cell unit. The data entry routine also comprises instructions for recording the characterization information about the plurality of stem cell transplant units in the stem cell database.
Patent NZ-560328-A (NZ)
Title: Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
Inventor: JIANG SHIBO
IPC: A61K39/215
Filed: 2006-02-08
Abstract: Provided is an isolated neutralizing monoclonal antibody capable of binding to the receptor binding domain of the spike protein of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) wherein the antibody is produced by Hybridoma 30F9 with ATCC Accession No. PTA6523.
Patent NZ-563627-A (NZ)
Title: Interconnected vacuum insulated panels embedded in single body of expanded foam between facings
Inventor: CAROLAN JAMES
IPC: B62D33/04
Filed: 2006-01-13
Abstract: An insulating panel comprises facing sheets with a body of insulating foam between the sheets. The insulating material has vacuum insulated panels (4) embedded therein and interconnected to each other via interconnections 15. The panel is substantially thinner than corresponding panels without vacuum insulated panels (4).
Patent NZ-573013-A (NZ)
Title: Medicinal compositions containing honey
Inventor: MOLONEY ANTHONY PETER
IPC: A61K35/644
Filed: 2007-05-31
Abstract: Disclosed is the use of a composition including a honey filtrate wherein: a. the honey is selected from the Leptospermum species, b. the filtrate excludes particles with a diameter of greater than 25 microns, c. the filtrate has non-peroxide antibacterial activity and does not undergo bacterial spoilage normally associated with honey at moisture contents greater than 19% water by weight, and d. the composition includes 19% to 80% water by weight and has a water activity of 0.63 to 0.85, in the manufacture of a medicament for treating microbial based respiratory conditions.
Patent NZ-573775-A (NZ)
Title: Method for introducing sirna into cells by photochemical internalisation
Inventor: BOE SIGURD
IPC: C12N15/11
Filed: 2007-07-11
Abstract: Disclosed is a method for introducing an siRNA molecule into the cytosol of a cell, said method comprising i) contacting said cell with an siRNA molecule, a carrier and a photosensiting agent, and ii) irradiating the cell with light of a wavelength effective to activate the photosensitising agent, wherein said carrier comprises a cationic polyamine such as a lipopolyamine in a non-liposomal formulation, polyethyleneimine (PEI), a betacyclodextrin amine polymer, an amine group containing dendrimer, and a cationic peptide. Cells or a population of cells obtainable by the method, a composition containing an siRNA molecule and the carrier molecule, kits and therapeutic uses of the above are also provided.
Patent NZ-580731-A (NZ)
Title: Coated oral nicotine formulation buffered with amino acid
Inventor: ANDERSSON SVEN-BORJE
IPC: A24B15/16
Filed: 2008-04-21
Abstract: Disclosed is a coated pharmaceutical product for intraoral delivery of nicotine comprising at least one buffered or non-buffered core, nicotine in any forn and/or a nicotine mimicking agent selected from one or more of capsaicin, piperine and zingerone, at least one coating layer and optionally one or more other additive(s), wherein said at least one coating layer comprises a buffering agent comprising at least one amino acid selected from the group consisting of Arginine, Aspargine, Glutamic acid, Glutamine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Serine, Threonine, Valine, Cysteic acid, N-Glycylglycine and Ornithine, and salts of any of the foregoing, and wherein the product further comprises a pH-adjusting compound when the pH-adjusting capacity of said at least one amino acid and/or a salt thereof is insufficient to increase the pH of the saliva of a subject to whom the product is administered to at least about 7. Further disclosed is the use of said product in the preparation of a medicament for delivering nicotine in any form to a subject, wherein the medicament is for oral administration such that the nicotine is released in the saliva in the oral cavity and absorbed into the systemic circulation of the subject. Also disclosed is a system for delivering nicotine in any form to a subject, comprising said coated product and at least one other product for obtaining reduction of the urge to smoke or use tobacco. Also disclosed is a method for producing said coated product, wherein the product is a chewing gum or a tablet. Also disclosed is the use of said product for use in the treatment of nicotine dependence, Alzheimer's disease, Crohn's disease, Parkinson's disease, Tourette's syndrome, ulcerous colitis and post-smoking-cessation weight control.
Patent NZ-582087-A (NZ)
Title: Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes
Inventor: JOHNSON ERIC A
IPC: C07K1/00
Filed: 2008-06-27
Abstract: Disclosed is an isolated plasmid, wherein the plasmid is a native plasmid found in a C. botulinum type A strain Loch Maree [subtype A3] and encodes BoNT/A3, or a native homolog of said plasmid.
Patent NZ-585675-A (NZ)
Title: New and gentle process for conversion of cystine in keratin-containing materials to lanthionine
Inventor: BRANHAM KEITH EDWARD
IPC: D06M11/32
Filed: 2005-06-09
Abstract: Provided is a composition comprising isolated keratin proteins comprising cystine residues wherein a first portion of the cystine residues are converted to lanthionine in a non-oxidative process and subsequently a second portion of the cystine residues are converted to cysteic acid. The composition can comprise cations associated with negatively charged regions of the proteins and water-insoluble beta-keratin proteins.
Patent NZ-588747-A (NZ)
Title: Method of increasing fluid flow through an extruder
Inventor: JOHNSON WILLIAM L
IPC: B29C48/41
Filed: 2009-05-26
Abstract: A method of increasing fluid flow through a member, typically an extruder. The method includes: feeding a fluid into the extruder; feeding a material into the extruder, the material comprised of particles having a sharp blade-like surface and an aspect ratio larger than 0.7; passing the material through a mixing zone in the extruder to disperse the material within the fluid wherein the material migrates to a boundary layer of the fluid to promote kinetic mixing within the fluid, the kinetic mixing taking place in a non-linear viscosity zone.
Patent NZ-592349-A (NZ)
Title: Blade assembly facing different directions at different locations along rotating shaft
Inventor: ISENBERG TIMOTHY J
IPC: B26D1/00
Filed: 2011-04-19
Abstract: A food processing vat system (5) comprising: a vat (7) defining an inside space therein; a shaft (105) rotating within the inside space of the vat; and a blade assembly (110) mounted to the shaft and having a length and a width. The blade assembly faces different directions at different locations along at least one of the length and the width. The blade assembly has a curved profile such that at different locations along the length of the curved profile, the blade assembly faces different directions.
Patent NZ-596244-A (NZ)
Title: Treatment of neurodegenerative diseases
Inventor: HOVENS CHRISTOPHER
IPC: A61K33/04
Filed: 2007-03-29
Abstract: 596244 Disclosed is a method of enhancing the activity of PP2A in a cell comprising administering to the cell an effective amount of selenate or a pharmaceutically acceptable salt thereof, wherein the cell is in vitro. Further disclosed is a method for inhibiting the activity of GSK3b in a neuron or glial cell, comprising exposing the cell to an effective amount of selenate or a pharmaceutically acceptable salt thereof, wherein the cell is in vitro.
Patent NZ-596599-A (NZ)
Title: Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
Inventor: FRESNO ESCUDERO MANUEL
IPC: A61K39/00
Filed: 2009-12-31
Abstract: 596599 Discloses the use of a lipopolysaccharide from Ochrobactrum intermedium LMG3306 in the manufacture of a medicament for the treatment of sepsis and a disease associated with decreased ability of the immune system. Also disclosed is a method of preparation and extraction of the lipopolysaccharide from the cultured bacterium.
Patent NZ-601483-A (NZ)
Title: Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
Inventor: WITYAK JOHN
IPC: A61K31/426
Filed: 2009-08-04
Abstract: Disclosed herein are the used of 2-,4-,6-substituted pyrimidine compounds of formula I, wherein the substituents are as defined within the specification, in the manufacture of a medicament for the treatment of Huntington's disease.
Patent NZ-606757-A (NZ)
Title: Grid runner
Inventor: LEHANE JAMES J
IPC: E04B9/24
Filed: 2011-07-22
Abstract: 606757 A roll-formed grid runner comprising a sheet metal strip folded into an upper hollow single wall reinforcing bulb, a double wall web below the bulb, a channel extending laterally from both sides of a lower end of the web to a bend and upwardly from the bend to a panel supporting elevation, the bend on each side of the web existing at a longitudinally extending score line where a thickness of the strip is locally reduced.
Patent NZ-610234-A (NZ)
Title: A teatcup liner and a teatcup
Inventor: Älveby Nils
IPC: A01J5/08
Filed: 2011-11-17
Abstract: 610234 A teatcup liner (2) for a teatcup (1) to be attached to a teat of an animal in a milking operation is disclosed. The teatcup liner (2) is composed of at least three separate annular sections (11-13), which are attached to each other and arranged successively along the longitudinal centre axis (x). The three sections include a first section (11) having an opening for allowing the teat to be introduced into the inner space, a second section (12) forming a tube part (16) to engage the teat during the milking operation and a third section (13) forming a ring module. The ring module has an inner surface facing the inner space and comprises a functional member (40) which provides an additional function to the milking operation. The sections (11-13) are engageable with each other interchangeably to allow various configurations of teat cup liners (2) to be manufactured from compatible sections.
Patent NZ-613689-A (NZ)
Title: Agent for improving deteriorated peripheral sensation due to aging and/or disease
Inventor: UEDA NORIKO
IPC: A61Q19/00
Filed: 2012-01-13
Abstract: Disclosed is a use of a milk-derived basic protein fraction in the manufacture of a medicament for improving deteriorated peripheral sensation due to ageing and/or a disease.
Patent NZ-615070-A (NZ)
Title: Npp1 fusion proteins
Inventor: QUINN ANTHONY
IPC: C12N15/86
Filed: 2011-09-15
Abstract: Discloses an isolated nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) fusion protein, comprising an NPP1 component, an Fc region of an immunoglobulin and optionally a targeting moiety, wherein a) the NPP1 component comprises the cysteine-rich region and the C-terminus catalytic domain of NPP1 and lacks the N-terminal cytosolic and transmembrane domains, b) the Fc region and the optional targeting moiety, when present, are each located C-terminally to the NPP1 component, and c) the isolated NPP1 fusion protein has NPP1 enzymatic activity.
Patent NZ-615861-A (NZ)
Title: Monitoring recombinase polymerase amplification mixtures
Inventor: ARMES NIALL A
IPC: G01N21/64
Filed: 2012-04-06
Abstract: Disclosed is a process comprising: (a) providing a mixture comprising: (i) a first subset of particles comprising a recombinase, a single-stranded DNA binding protein (SSB) and a first oligonucleotide comprising a first detectable label; and (ii) a second subset of particles comprising a recombinase, a single-stranded DNA binding protein (SSB) and a second oligonucleotide comprising a second detectable label, wherein: -the first oligonucleotide and the second oligonucleotide are different; and -the first detectable label and the second detectable label are different; and (b) independently observing or determining the number or proportion of the first subset of particles and the second subset of particles in the mixture, wherein the particles comprise one or more of the recombinase, the single-stranded DNA binding protein (SSB) and at least one of the first oligonucleotide and the second oligonucleotide. Also disclosed is a process comprising: (a) providing a mixture comprising a recombinase, a single-stranded DNA binding protein and one or more oligonucleotides; and (b) detecting particles associated with nucleic acid amplification products in the mixture by observing particles or determining the number or proportion of particles associated with the nucleic acid amplification products in the mixture.
Patent NZ-629920-A (NZ)
Title: A method for making an inhalable pharmaceutical composition using a resonant acoustic blender
Inventor: GREEN MATTHEW
IPC: B01F11/02
Filed: 2013-03-28
Abstract: A method is disclosed for making a pharmaceutical composition for pulmonary administration, the method comprising a step in which an inhalable pharmaceutically active material is acoustically blended in a resonant acoustic blender, wherein the pharmaceutical composition is for localised pulmonary administration, and wherein the pharmaceutically active material is selected from budesonide, formoterol fumarate, glycopyrronium bromide, indacaterol maleate, umeclidinium bromide, vilanterol trifenatate, tiotropium bromide, salmeterol xinafoate or fluticasone propionate, and wherein the pharmaceutical composition comprises a particulate excipient material such as alpha-lactose monohydrate in particulate form.
Patent NZ-700021-A (NZ)
Title: Systems and methods for determining compatibility of an implant for a medical procedure
Inventor: ROE MICHAEL
IPC: G06F19/00
Filed: 2013-03-21
Abstract: Method and apparatus for use in the field of implants and associated medical procedures which determines a compatibility of an implant for a specified medical procedure during such procedure. The compatibility determination is facilitated by identifying a body location associated with the specified medical procedure, and determining, during the specified medical procedure, compatibility of the implant, based on data identifying an implant, certain product use information associated with the implant, and the identification of the body location associated with the specified medical procedure.
Patent NZ-704291-A (NZ)
Title: A combined baler/bale wrapper
Inventor: HEANEY JAMES JOHN
IPC: A01F15/07
Filed: 2013-08-13
Abstract: A combined baler/bale wrapper (1) comprises a baler (10) mounted on a chassis (5) and a bale wrapper (14) mounted on the chassis (5) rearwardly of the baler (10) for wrapping a bale formed by the baler (10). The bale wrapper (14) comprises a pair of first and second bale support rollers (50,51 ) for supporting and rotating the bale about a first wrapping axis (56). A pair of wrapping film dispensers (60) are carried on a carrier ring (58) which is rotated about a second wrapping axis (61) for dispensing wrapping film onto the bale (2) as the bale (2) is being rotated by the first and second bale support rollers (50,51). The first bale support roller (50) is carried on a transfer element (16) so that as the transfer element (16) is pivoted about a transfer pivot axis (17) from a first state to a second state for transferring the bale (2) onto the bale wrapper (14) the first bale support roller (50) is urged in a downwardly direction (F) in order to maximise the headroom available to the bale (2) as the bale (2) is being transferred by the transfer element (16) to the bale wrapper (14).
Patent NZ-715498-A (NZ)
Title: Connection system and method for electrical outlets
Inventor: DE MAN GERRIT
IPC: H05K5/02
Filed: 2015-12-22
Abstract: A system comprising an electrical outlet with a mounting region 220 and a component 100 connected to the mounting region, where the component 100 is connected to the mounting region 220 by a sliding connector 400 which passes through an aperture 222 in the mount 220 and engages a retaining surface on the component 100. The system provides for faster and more convenient connection and disconnection of electrical devices.
Patent NZ-716543-A (NZ)
Title: System and method for balanced refuelling of a plurality of compressed gas pressure vessels
Inventor: WHITEMAN PAUL ANTHONY
IPC: F17C13/00
Filed: 2014-08-08
Abstract: A pressure vessel balanced refuelling system enables greater volumes of gas to be used as working volumes and increases gas storage efficiency. The system includes a plurality of pressure vessels, each vessel having a liquid transfer opening for the entry and exit of a liquid that is used to displace a gas inside each vessel. A liquid transfer line extends from an outside to an inside of each vessel in the plurality of pressure vessels through the liquid transfer opening, and a liquid balance line inter- connects the liquid transfer opening of each vessel with the liquid transfer opening of each other vessel. Thus a balance liquid transfer path extends from an inside to an outside of one vessel, then from the outside to the inside of each other vessel through the liquid balance line, enabling a liquid level in the one vessel to remain approximately equal to a liquid level in each other vessel. The system disclosed therefore solves the problem of differences in liquid levels and pressure across the plurality of vessels caused by, for example, pump pressure pulses and unequal flow losses.
Patent NZ-719746-A (NZ)
Title: Improvements in panel connection
Inventor: DALLAS REX JAMES
IPC: G10K11/16
Filed: 2016-05-04
Abstract: The present invention provides a hollow double tongued joint between vertically adjacent panels which increases sound absorbance and sound resistance.
Patent NZ-721051-A (NZ)
Title: Tropomyosin-related kinase (trk) inhibitors
Inventor: KANE JOHN L
IPC: C07D403/14
Filed: 2014-12-10
Abstract: 1H-benzo[d]imidazole and 3H-imidazo[4,5-d]pyridine derivatives as disclosed as tropomyosin-related kinase inhibitors (Trk inhibitors) useful in the treatment of disease. These Trk inhibitors can be used as pharmaceutical agents and in pharmaceutical compositions. Trk inhibitors are useful in the treatment of inflammatory diseases, autoimmune disease, defects of bone metabolism and/or cancer, and are particularly useful in the treatment of osteoarthritis (OA), pain, and pain associated with OA. Trk inhibitors are also useful for inhibiting tropomyosin-related kinase A (TrkA), tropomyosin-related kinase B (TrkB), tropomyosin-related kinase C (TrkC), and/or c-FMS (the cellular receptor for colony stimulating factor-1 (CSF-1)).
Patent NZ-731138-A (NZ)
Title: A moveable irrigator
Inventor: LYNN PETER ROBERT
IPC: B05B3/18
Filed: 2015-11-30
Abstract: A moveable irrigator (1) having a wheeled support structure and a plurality of deflectors (10) of such a size, distribution and orientation as to apply a stabilising downforce on an upwind side or a stabilising upforce on a downwind side to the support structure when exposed to the force of incident wind. The invention reduces the risk of an unanchored mobile irrigator toppling over when subjected to forces caused by incident winds.
Patent NZ-735397-A (NZ)
Title: Tapered beam
Inventor: NICHOLAS ALEXANDER STEPHEN CLEMENTS
IPC: E04C3/07
Filed: 2014-08-26
Abstract: A closed-section profile tapered beam is disclosed for use in the construction industry formed from two nested C-section tapered beams 7, typically formed by a gradual uniform taper of the web of each C-section.
Patent NZ-742707-A (NZ)
Title: Detection system for front of a vehicle
Inventor: ERRINGTON ROWLAND
IPC: B65F3/02
Filed: 2016-11-07
Abstract: The present invention is a detection system for the front of a vehicle with front lift arms for lifting and lowering a bin. The detection system including two sensors that are spaced apart and positioned on the front of the vehicle to detect the presence of an object or person and control means to receive and process sensor input to control the operation of the lifting arms. Each sensor including a motion sensor and a proximity sensor. The detection system defines a first zone, the first zone covering the space through which the bin moves between a raised and a lowered position, and a second zone, the second zone being the space surrounding the first zone. When the presence of the object or person is detected within a first zone or second zone, the movement of the lifting arms is stopped. When the movement of the lifting arms is stopped the lowering of the bin will not resume until the sensors no longer detect the presence or movement of an object or person and/or are manually overridden. When the bin is lowered to the ground, the detection system is automatically reset in preparation for a new sequence.
Patent NZ-745475-A (NZ)
Title: Apparatus for controlling fermentation of natural material
Inventor: PESONEN NADINE
IPC: C12M1/36
Filed: 2017-01-20
Abstract: Fermentation can cause spontaneous combustion in natural material. It can be reduced with chemical agents, however only manual probes exist to read out temperature and humidity. There is a need for a more refined solution for controlling the fermentation. An apparatus (100) for controlling fermentation of natural material includes one or more sensors (102) configured to measure at least one property of natural material (150), a container (104) configured to contain a chemical reactive agent (106) reducing or limiting a fermentation process of the natural material (150); a valve (108) coupled with the container (104); and a controller (110) configured to process the measured at least one property of the natural material (150), and, if the processing meets a predetermined condition, control the valve (108) to open so that the chemical reactive agent (106) is released into the natural material (150) in order to limit the fermentation process of the natural material (150). Accordingly, desired properties and quality of the natural material may be maintained and/or a spontaneous combustion of the natural material may be inhibited.